000 | 01997 a2200553 4500 | ||
---|---|---|---|
005 | 20250517043820.0 | ||
264 | 0 | _c20160907 | |
008 | 201609s 0 0 eng d | ||
022 | _a1526-7598 | ||
024 | 7 |
_a10.1213/ANE.0000000000000869 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSu, Felice | |
245 | 0 | 0 |
_aDexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery. _h[electronic resource] |
260 |
_bAnesthesia and analgesia _cMay 2016 |
||
300 |
_a1556-66 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAdrenergic alpha-2 Receptor Agonists _xadministration & dosage |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAnalgesics, Non-Narcotic _xadministration & dosage |
650 | 0 | 4 | _aCardiac Surgical Procedures |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aComputer Simulation |
650 | 0 | 4 |
_aDexmedetomidine _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Dosage Calculations |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 |
_aHeart Defects, Congenital _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypnotics and Sedatives _xadministration & dosage |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aMonte Carlo Method |
650 | 0 | 4 | _aNonlinear Dynamics |
650 | 0 | 4 | _aRespiration, Artificial |
650 | 0 | 4 | _aTandem Mass Spectrometry |
650 | 0 | 4 | _aTerm Birth |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGastonguay, Marc R | |
700 | 1 | _aNicolson, Susan C | |
700 | 1 | _aDiLiberto, MaryAnn | |
700 | 1 | _aOcampo-Pelland, Alanna | |
700 | 1 | _aZuppa, Athena F | |
773 | 0 |
_tAnesthesia and analgesia _gvol. 122 _gno. 5 _gp. 1556-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1213/ANE.0000000000000869 _zAvailable from publisher's website |
999 |
_c25116843 _d25116843 |